Literature DB >> 22430350

GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia.

Hiroyuki Ishida1, Kosuke Imai, Kenichi Honma, Shin-Ichi Tamura, Toshihiko Imamura, Masafumi Ito, Shigeaki Nonoyama.   

Abstract

A Japanese patient presented with lymphedema, severe Varicella zoster, and Salmonella infection, recurrent respiratory infections, panniculitis, monocytopenia, B- and NK-cell lymphopenia, and myelodysplasia. The phenotype was a mixture of the monocytopenia and mycobacterial infection (MonoMAC) and Emberger syndromes. Sequencing of the GATA-2 cDNA revealed the heterozygous missense mutation 1187 G > A. This mutation resulted in the amino acid mutation Arg396Gln in the zinc fingers-2 domain, which is predicted to cause significant structural change and prevent a critical interaction with DNA. Functional analysis of the patient's GATA-2 mutation is required to understand the relationship between these distinctive syndromes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430350     DOI: 10.1007/s00431-012-1715-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes.

Authors:  H Tamaki; H Ogawa; K Ohyashiki; J H Ohyashiki; H Iwama; K Inoue; T Soma; Y Oka; T Tatekawa; Y Oji; A Tsuboi; E H Kim; M Kawakami; K Fuchigami; M Tomonaga; K Toyama; K Aozasa; T Kishimoto; H Sugiyama
Journal:  Leukemia       Date:  1999-03       Impact factor: 11.528

Review 2.  Immunity to microbes: lessons from primary immunodeficiencies.

Authors:  Magda Carneiro-Sampaio; Antonio Coutinho
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

3.  Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency.

Authors:  Jennifer Cuellar-Rodriguez; Juan Gea-Banacloche; Alexandra F Freeman; Amy P Hsu; Christa S Zerbe; Katherine R Calvo; Jennifer Wilder; Roger Kurlander; Kenneth N Olivier; Steven M Holland; Dennis D Hickstein
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

4.  Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases.

Authors:  Sahar Mansour; Fiona Connell; Colin Steward; Pia Ostergaard; Glen Brice; Sarah Smithson; Peter Lunt; Steve Jeffery; Inderjeet Dokal; Tom Vulliamy; Brenda Gibson; Shirley Hodgson; Sally Cottrell; Louise Kiely; Lorna Tinworth; Kamini Kalidas; Ghulam Mufti; Jackie Cornish; Russell Keenan; Peter Mortimer; Victoria Murday
Journal:  Am J Med Genet A       Date:  2010-09       Impact factor: 2.802

5.  Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome).

Authors:  Pia Ostergaard; Michael A Simpson; Fiona C Connell; Colin G Steward; Glen Brice; Wesley J Woollard; Dimitra Dafou; Tatjana Kilo; Sarah Smithson; Peter Lunt; Victoria A Murday; Shirley Hodgson; Russell Keenan; Daniela T Pilz; Ines Martinez-Corral; Taija Makinen; Peter S Mortimer; Steve Jeffery; Richard C Trembath; Sahar Mansour
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

6.  Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia.

Authors:  Donald C Vinh; Smita Y Patel; Gulbu Uzel; Victoria L Anderson; Alexandra F Freeman; Kenneth N Olivier; Christine Spalding; Stephen Hughes; Stefania Pittaluga; Mark Raffeld; Lynn R Sorbara; Houda Z Elloumi; Douglas B Kuhns; Maria L Turner; Edward W Cowen; Danielle Fink; Debra Long-Priel; Amy P Hsu; Li Ding; Michelle L Paulson; Adeline R Whitney; Elizabeth P Sampaio; David M Frucht; Frank R DeLeo; Steven M Holland
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

7.  Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromes.

Authors:  Hideto Tamura; Kazuo Dan; Norio Yokose; Rika Iwakiri; Masatsugu Ohta; Hisashi Sakamaki; Kaoru Tohyama; Asaka Kondo; Hideya Hyodo; Kyoko Nakamura; Taishi Yamashita; Olga A Elisseeva; Yoshihiro Oka; Yusuke Oji; Haruo Sugiyama; Kiyoyuki Ogata
Journal:  Leuk Res       Date:  2010-01-19       Impact factor: 3.156

8.  Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency.

Authors:  Rachel Emma Dickinson; Helen Griffin; Venetia Bigley; Louise N Reynard; Rafiqul Hussain; Muzlifah Haniffa; Jeremy H Lakey; Thahira Rahman; Xiao-Nong Wang; Naomi McGovern; Sarah Pagan; Sharon Cookson; David McDonald; Ignatius Chua; Jonathan Wallis; Andrew Cant; Michael Wright; Bernard Keavney; Patrick F Chinnery; John Loughlin; Sophie Hambleton; Mauro Santibanez-Koref; Matthew Collin
Journal:  Blood       Date:  2011-07-15       Impact factor: 22.113

9.  GATA-2 regulates granulocyte-macrophage progenitor cell function.

Authors:  Neil P Rodrigues; Ashleigh S Boyd; Cristina Fugazza; Gillian E May; Yanping Guo; Alex J Tipping; David T Scadden; Paresh Vyas; Tariq Enver
Journal:  Blood       Date:  2008-10-07       Impact factor: 22.113

10.  Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.

Authors:  Christopher N Hahn; Chan-Eng Chong; Catherine L Carmichael; Ella J Wilkins; Peter J Brautigan; Xiao-Chun Li; Milena Babic; Ming Lin; Amandine Carmagnac; Young K Lee; Chung H Kok; Lucia Gagliardi; Kathryn L Friend; Paul G Ekert; Carolyn M Butcher; Anna L Brown; Ian D Lewis; L Bik To; Andrew E Timms; Jan Storek; Sarah Moore; Meryl Altree; Robert Escher; Peter G Bardy; Graeme K Suthers; Richard J D'Andrea; Marshall S Horwitz; Hamish S Scott
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

View more
  24 in total

Review 1.  Anemia of Central Origin.

Authors:  Kazusa Ishii; Neal S Young
Journal:  Semin Hematol       Date:  2015-07-09       Impact factor: 3.851

Review 2.  MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature.

Authors:  Jose F Camargo; Stephen A Lobo; Amy P Hsu; Christa S Zerbe; Gary P Wormser; Steven M Holland
Journal:  Clin Infect Dis       Date:  2013-05-31       Impact factor: 9.079

3.  Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.

Authors:  Jeffrey I Cohen; Lesia Dropulic; Amy P Hsu; Christa S Zerbe; Tammy Krogmann; Kennichi Dowdell; Ronald L Hornung; Jana Lovell; Nancy Hardy; Dennis Hickstein; Edward W Cowen; Katherine R Calvo; Stefania Pittaluga; Steven M Holland
Journal:  Clin Infect Dis       Date:  2016-05-11       Impact factor: 9.079

4.  A woman with warts, leg swelling, and deafness.

Authors:  Melissa A Muszynski; Christa S Zerbe; Steven M Holland; Heidi H Kong
Journal:  J Am Acad Dermatol       Date:  2014-09       Impact factor: 11.527

5.  Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning.

Authors:  Kim-Chew Lim; Tomonori Hosoya; William Brandt; Chia-Jui Ku; Sakie Hosoya-Ohmura; Sally A Camper; Masayuki Yamamoto; James Douglas Engel
Journal:  J Clin Invest       Date:  2012-09-10       Impact factor: 14.808

Review 6.  Rheumatologic manifestations of the "MonoMAC" syndrome. a systematic review.

Authors:  Jennifer A Johnson; Steven S Yu; Michael Elist; Daniel Arkfeld; Richard S Panush
Journal:  Clin Rheumatol       Date:  2015-03-05       Impact factor: 2.980

Review 7.  Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).

Authors:  Anna L Brown; Christopher N Hahn; Hamish S Scott
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

Review 8.  A genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections.

Authors:  Un-In Wu; Steven M Holland
Journal:  Semin Immunopathol       Date:  2016-01-05       Impact factor: 9.623

9.  GATA2 is required for lymphatic vessel valve development and maintenance.

Authors:  Jan Kazenwadel; Kelly L Betterman; Chan-Eng Chong; Philippa H Stokes; Young K Lee; Genevieve A Secker; Yan Agalarov; Cansaran Saygili Demir; David M Lawrence; Drew L Sutton; Sebastien P Tabruyn; Naoyuki Miura; Marjo Salminen; Tatiana V Petrova; Jacqueline M Matthews; Christopher N Hahn; Hamish S Scott; Natasha L Harvey
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

10.  GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2.

Authors:  Silvia Coma; Marc Allard-Ratick; Tomoshige Akino; Laurens A van Meeteren; Akiko Mammoto; Michael Klagsbrun
Journal:  Angiogenesis       Date:  2013-07-28       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.